Chemodex

Formononetin

CHF 37.00
In stock
CDX-F0339-M05050 mgCHF 37.00
More Information
Product Details
Synonyms Biochanin B; NSC 93360; 7-Hydroxy-3-(4-methoxyphenyl)-4H-1-benzopyran-4-one; 7-Hydroxy-3-(4-methoxyphenyl)chromone, 7-Hydroxy-4'-methoxyisoflavone
Product Type Chemical
Properties
Formula C16H12O4
MW 268.26
CAS 485-72-3
RTECS DJ3100114
Purity Chemicals ≥98% (HPLC)
Appearance White to off-white powder.
Solubility Soluble in DMSO (30mg/ml), DMF (30mg/ml) or ethanol (1mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key HKQYGTCOTHHOMP-UHFFFAOYSA-N
Smiles OC1=CC=C(C(C(C2=CC=C(OC)C=C2)=CO3)=O)C3=C1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Formononetin is an isoflavonoid phytoestrogenic compound found in soy-based foods and is the precursor of daidzein. It acts as an agonist of the aryl hydrocarbon receptor and a selective inhibitor of ADH γ (the γ-isoform of alcohol dehydrogenase). It displays potent antitumor, antiviral, anti-inflammatory (inhibits NLRP3 inflammasome), antioxidant, neuroprotective and neuroinflammatory properties. Also shown to have vasorelaxant, antihypertensive and antihyperglycemic (AMPK activator) properties. Induces cell cycle arrest and apoptosis in several cancer cells in vitro and in vivo and shows anti-angiogenic (FGFR2 inhibitor), anti-invasive and anti-migratory effects. Increases adipocyte thermogenesis by modulating PPARγ activity. Shown to promote early fracture healing through stimulating angiogenesis by up-regulating VEGFR-2/Flk-1 and endothelial repair and wound healing in a process involving the over-expression of Egr-1 transcription factor through the regulation of the ERK1/2 and p38 MAPK pathways.

Binding to human cell-surface receptor HSPA5 and prevents SARS-CoV-2 spike protein from binding to HSPA5 SBDβ in silico.

Product References

(1) W.M. Keung; BBRC 215, 1137 (1995) | (2) S. Toda and Y. Shirataki; Phytother. Res. 13, 163 (1999) | (3) C.K. Wong & W.M. Keung; J. Steroid Biochem. Mol. Biol. 71, 191 (1999) | (4) B.L. Pool-Zobel, et al.; Carcinogenesis 21, 1247 (2000) | (5) S. Medjakovic & A. Jungbauer ; J. Steroid Biochem. Mol. Biol 108, 171 (2008) | (6) H. Mu, et al.; Phytomedicine 16, 314 (2009) | (7) J.E . Huh, et al.; Int. Immunopharmacol. 9, 1357 (2009) | (8) J.E . Huh, et al.; Int. Immunopharmacol. 11, 46 (2011) | (9) T. Sun, et al.; Acta Pharmacol. Sin. 32, 1009 (2011) | (10) J. Chen, et al.; Horm. Metab. Res. 43, 681 (2011) | (11) M. Sun, et al.; J. Alzheimers Dis. 28, 795 (2012) | (12) Y. Ye, et al.; Horm. Metab. Res. 44, 263 (2012) | (13) K.K. Auyeung, et al.; Oncol. Rep. 28, 2188 (2012) | (14) R. Zhou, et al.; Horm. Metab. Res. 46, 753 (2014) | (15) Y. Yang, et al.; Int. J. Clin. Exp. Pathol. 7, 8453 (2014) | (16) X.Y. Wu, et al.; Oncotarget 6, 44563 (2015) | (17) H. Wang, et al.; Virol. J. 12, 1 (2015) | (18) G. Qiu, et al.; Exp. Biol. Med. 242, 223 (2017) | (19) J. Gautam, et al.; Br. J. Nutr. 117, 645 (2017) | (20) T. Nie, et al.; Br. J. Pharmacol. 175, 1439 (2018) | (21) D. Wu, et al.; Mediators Inflamm. 2018, 3048532 (2018) | (22) A. El-Bakoush & O.A. Olajide; Int. Immunopharmacol. 61, 325 (2018)

Natural products may interfere with SARS-CoV-2 attachment to the host cell: A.A. Elfiky, J. Biomol. Struct. Dyn. 1 (2020)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.